Published in Med Sci Sports Exerc on February 01, 1986
Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol (2003) 2.13
Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair. Mov Disord (2003) 1.28
Reliability of lower extremity strength measures in persons with chronic stroke. Arch Phys Med Rehabil (2002) 1.22
Effects of isokinetic strength training on walking in persons with stroke: a double-blind controlled pilot study. J Stroke Cerebrovasc Dis (2007) 1.15
The application of isokinetics in testing and rehabilitation of the shoulder complex. J Athl Train (2000) 1.14
Effects of isokinetic velocity spectrum exercise on average power and total work. J Athl Train (1992) 1.00
Posterior rotator cuff strengthening using theraband(r) in a functional diagonal pattern in collegiate baseball pitchers. J Athl Train (1993) 0.98
Eccentric and concentric isokinetic knee flexion and extension: a reliability study using the Cybex 6000 dynamometer. Br J Sports Med (1996) 0.93
An evaluation of differences in hip external rotation strength and range of motion between female dancers and non-dancers. Br J Sports Med (2004) 0.92
Effect of whirlpool therapy on the signs and symptoms of delayed-onset muscle soreness. J Athl Train (1998) 0.89
Objective assessment of shoulder mobility with a new 3D gyroscope--a validation study. BMC Musculoskelet Disord (2011) 0.89
Flexible foil exercise and shoulder internal and external rotation strength. J Athl Train (2006) 0.89
Muscle mechanical characteristics in fatigue and recovery from a marathon race in highly trained runners. Eur J Appl Physiol (2007) 0.86
Reliability of ankle dorsiflexion passive range of motion measurements obtained using a hand-held goniometer and Biodex dynamometer in stroke patients. J Phys Ther Sci (2015) 0.86
Skeletal muscle strength and endurance in recipients of lung transplants. Cardiopulm Phys Ther J (2008) 0.81
The Reliability Of Three Isokinetic Knee-extension Angle-specific Torques. J Athl Train (1993) 0.76
Elastic properties of muscle measured at the elbow in man. Defining velocity sensitive resistance to passive movement in a clinically measurable manner. J Neurol Neurosurg Psychiatry (1989) 0.75
Drugs, HIV, and prisons. BMJ (1991) 4.52
Socioeconomic status, standard of living, and neurotic disorder. Lancet (1998) 3.80
A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med (1999) 3.10
The Swiss heroin trials: testing alternative approaches. BMJ (1998) 3.00
Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry (2000) 2.91
The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. Psychol Med (1997) 2.74
Two simple methods for determining gait events during treadmill and overground walking using kinematic data. Gait Posture (2007) 2.48
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
Britain's new strategy for tackling drugs misuse. Shows a welcome emphasis on evidence. BMJ (1998) 2.34
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Drug regimens that break a country's drug laws. BMJ (1993) 2.20
Unequal access and unmet need: neurotic disorders and the use of primary care services. Psychol Med (2000) 2.08
Comorbidity of mental disorders with substance misuse. Br J Psychiatry (1997) 2.04
Policy on drug misuse in Europe. BMJ (1994) 1.98
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol (1998) 1.96
Harm minimisation for drug misusers. BMJ (1992) 1.91
Clinical features of patients attending a gender-identity clinic. Br J Psychiatry (1990) 1.82
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79
Role of small t antigen in the acute transforming activity of SV40. Cell (1982) 1.76
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity . Psychol Med (1998) 1.67
Neurotic disorders and the receipt of psychiatric treatment. Psychol Med (2000) 1.66
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.59
Well users clinic for illicit drug users. BMJ (1989) 1.57
Misuse of temazepam. BMJ (1988) 1.51
Suicide and overdose among opiate addicts. Addiction (1996) 1.51
Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc Natl Acad Sci U S A (1980) 1.50
Relative densities of synaptic and extrasynaptic GABAA receptors on cerebellar granule cells as determined by a quantitative immunogold method. J Neurosci (1995) 1.46
Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophr Res (1995) 1.44
Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction (2000) 1.42
cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res (1999) 1.41
British psychiatric morbidity survey. Br J Psychiatry (1998) 1.40
Antidepressants for cocaine dependence. Cochrane Database Syst Rev (2001) 1.40
Management of the pregnant opiate user. Br J Hosp Med (1990) 1.39
Beyond platitudes: Problem drug use: a review of training. Br J Addict (1990) 1.38
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. QJM (2011) 1.38
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2004) 1.35
Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature (1985) 1.35
The National Psychiatric Morbidity surveys of Great Britain--strategy and methods. Psychol Med (1997) 1.34
Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature (1981) 1.34
Fatal methadone and heroin overdoses: time trends in England and Wales. J Epidemiol Community Health (1997) 1.33
Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci (1998) 1.33
Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol (1994) 1.33
Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS. J Comp Neurol (1992) 1.32
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction (1999) 1.32
Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci (1992) 1.30
Reciprocal expression of gill Na+/K+-ATPase alpha-subunit isoforms alpha1a and alpha1b during seawater acclimation of three salmonid fishes that vary in their salinity tolerance. J Exp Biol (2006) 1.27
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry (2004) 1.26
In situ hybridization histochemistry reveals a diversity of GABAA receptor subunit mRNAs in neurons of the rat spinal cord and dorsal root ganglia. Neuroscience (1991) 1.26
National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis (2000) 1.26
Debt, income and mental disorder in the general population. Psychol Med (2008) 1.24
alpha-Actinin attached to membranes of secretory vesicles. Nature (1977) 1.20
Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration. J Clin Oncol (1984) 1.20
Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience (1996) 1.18
Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol (1993) 1.18
Immunocytochemical localization of the alpha 1 and beta 2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus. Eur J Neurosci (1995) 1.16
In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem (1998) 1.15
Functional characteristics and sites of gene expression of the alpha 1, beta 1, gamma 2-isoform of the rat GABAA receptor. J Neurosci (1990) 1.14
Drug use and initiation in prison: results from a national prison survey in England and Wales. Addiction (2002) 1.13
The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand (2003) 1.13
Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J Neurol (2006) 1.12
Platelets as a model for neurones? Experientia (1988) 1.12
Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone. BMJ (1996) 1.12
Phenformin as Adjuvant Oral Therapy in Diabetes. Br Med J (1961) 1.10
Gait variability in people with multiple sclerosis. Mult Scler (2006) 1.09
Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy. J Neurosci (2001) 1.09
Psychosocial treatment for opiate abuse and dependence. Cochrane Database Syst Rev (2005) 1.08
Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. J Neurosci (1987) 1.08
Noradrenaline contractions in rabbit mesenteric arteries skinned with saponin. J Physiol (1981) 1.07
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2001) 1.06
Ultrastructural cytochemistry of biogenic amines in nervous tissue: methodologic improvements. J Histochem Cytochem (1976) 1.06
An evaluation of head movement in backboard-immobilized helmeted football, lacrosse, and ice hockey players. Clin J Sport Med (2001) 1.06
The National Psychiatric Morbidity Surveys of Great Britain--initial findings from the household survey. Int Rev Psychiatry (2004) 1.06
Isolation of the cDNA for human prostaglandin H synthase. Prostaglandins (1986) 1.06
Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience (1994) 1.05
Psychiatric morbidity and substance use in young people aged 13-15 years: results from the Child and Adolescent Survey of Mental Health. Br J Psychiatry (2003) 1.05
The role of primordial emotions in the evolutionary origin of consciousness. Conscious Cogn (2008) 1.04
Distribution of indolealkylamine nerve terminals in the ventricles of the rat brain. Z Zellforsch Mikrosk Anat (1973) 1.03
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J Neurochem (2000) 1.02
The reluctance to seek treatment for neurotic disorders. Int Rev Psychiatry (2004) 1.02
Synteny between a major heading-date QTL in perennial ryegrass (Lolium perenne L.) and the Hd3 heading-date locus in rice. Theor Appl Genet (2003) 1.02
Visuo-motor disability in schoolchildren. Br Med J (1967) 1.01
Dissociation between biochemical and ultrastructural effects of 6-hydroxydopamine in rat brain. Experientia (1970) 1.01
The natural history of aortic dilatation in Marfan syndrome. Med J Aust (1993) 1.00
Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand. J Neurosci (1984) 0.99
'Horse trading': prescribing injectable opiates to opiate addicts. A descriptive study. Drug Alcohol Rev (1992) 0.99
Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction (1999) 0.98
A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant (2001) 0.98
Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology (2009) 0.98
Mapping of brain areas containing RNA homologous to cDNAs encoding the alpha and beta subunits of the rat GABAA gamma-aminobutyrate receptor. Proc Natl Acad Sci U S A (1988) 0.97
Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol Med (2006) 0.97
Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev (2008) 0.97
Subcellular localization of benzodiazepine/GABAA receptors in the cerebellum of rat, cat, and monkey using monoclonal antibodies. J Neurosci (1989) 0.97
In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med (1990) 0.97
Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev (1998) 0.97
Antidepressants for cocaine dependence. Cochrane Database Syst Rev (2003) 0.97
Subcellular localization of the heparin-neutralizing factor in blood platelets. J Physiol (1976) 0.97
Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions. Prog Brain Res (1969) 0.96
Lone mothers, social exclusion and depression. Psychol Med (2003) 0.96
Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology (2002) 0.95